191 related articles for article (PubMed ID: 21692745)
1. Identification of diuretic non-responders with poor long-term clinical outcomes: a 1-year follow-up of 176 non-azotaemic cirrhotic patients with moderate ascites.
Yang YY; Lin HC; Lin MW; Chu CJ; Lee FY; Hou MC; Lee SD; Lee WP; Liu TT; Jap TS
Clin Sci (Lond); 2011 Dec; 121(11):509-21. PubMed ID: 21692745
[TBL] [Abstract][Full Text] [Related]
2. Association of the G-protein and α2-adrenergic receptor gene and plasma norepinephrine level with clonidine improvement of the effects of diuretics in patients with cirrhosis with refractory ascites: a randomised clinical trial.
Yang YY; Lin HC; Lee WP; Chu CJ; Lin MW; Lee FY; Hou MC; Jap JS; Lee SD
Gut; 2010 Nov; 59(11):1545-53. PubMed ID: 20833658
[TBL] [Abstract][Full Text] [Related]
3. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
[TBL] [Abstract][Full Text] [Related]
5. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
Gatta A; Angeli P; Caregaro L; Menon F; Sacerdoti D; Merkel C
Hepatology; 1991 Aug; 14(2):231-6. PubMed ID: 1860680
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin-aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age.
Franco E; Palumbo L; Crobu F; Anselmino M; Frea S; Matullo G; Piazza A; Trevi GP; Bergerone S
BMC Med Genet; 2007 May; 8():27. PubMed ID: 17519002
[TBL] [Abstract][Full Text] [Related]
7. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
Lenaerts A; Codden T; Meunier JC; Henry JP; Ligny G
Hepatology; 2006 Oct; 44(4):844-9. PubMed ID: 17006921
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites.
Angeli P; Dalla Pria M; De Bei E; Albino G; Caregaro L; Merkel C; Ceolotto G; Gatta A
Hepatology; 1994 Jan; 19(1):72-9. PubMed ID: 8276370
[TBL] [Abstract][Full Text] [Related]
9. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
[TBL] [Abstract][Full Text] [Related]
10. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
[TBL] [Abstract][Full Text] [Related]
11. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Kosta P; Papadimitriou K; Tsianos EV
J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
[TBL] [Abstract][Full Text] [Related]
12. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
[TBL] [Abstract][Full Text] [Related]
13. [The renin-angiotensin-aldosterone system in liver cirrhosis].
Giudici Cipriani A; Folco U; Colombo P; Menardo G; Cattana A; Barbetti V; Rembado R; Marenco G
Minerva Med; 1990; 81(1-2):45-53. PubMed ID: 2314615
[TBL] [Abstract][Full Text] [Related]
14. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
Kuiper JJ; Boomsma F; van Buren H; de Man R; Danser AH; van den Meiracker AH
Eur J Clin Invest; 2008 Dec; 38(12):939-44. PubMed ID: 19021719
[TBL] [Abstract][Full Text] [Related]
15. Renal hemodynamics and the renin-angiotensin system in cirrhosis.
Aliaga L; Zozaya JM; Quiroga J; Richter JA; Prieto J
Rev Esp Fisiol; 1989; 45 Suppl():371-5. PubMed ID: 2701770
[TBL] [Abstract][Full Text] [Related]
16. Impact of genetic polymorphisms of the renin-angiotensin system and of non-genetic factors on kidney transplant function--a single-center experience.
Siekierka-Harreis M; Kuhr N; Willers R; Ivens K; Grabensee B; Mondry A; Loh MC; Rump LC; Blume C
Clin Transplant; 2009; 23(5):606-15. PubMed ID: 19681973
[TBL] [Abstract][Full Text] [Related]
17. The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: a multicentric study.
Fimiani B; Guardia DD; Puoti C; D'Adamo G; Cioffi O; Pagano A; Tagliamonte MR; Izzi A
Eur J Intern Med; 2011 Dec; 22(6):587-90. PubMed ID: 22075285
[TBL] [Abstract][Full Text] [Related]
18. Studies of renin and aldosterone in cirrhotic patients with ascites.
Rosoff L; Zia P; Reynolds T; Horton R
Gastroenterology; 1975 Sep; 69(3):698-705. PubMed ID: 1158087
[TBL] [Abstract][Full Text] [Related]
19. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
Arroyo V; Bosch J; Casamitjana R; Cabrera J; Rivera F; Rodés J
Gut; 1980 Oct; 21(10):855-9. PubMed ID: 7439805
[TBL] [Abstract][Full Text] [Related]
20. Total paracentesis in cirrhotic patients with tense ascites and dilutional hyponatremia.
Vila MC; Coll S; Solà R; Andreu M; Gana J; Marquez J
Am J Gastroenterol; 1999 Aug; 94(8):2219-23. PubMed ID: 10445553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]